Muller & Phipps (India) Ltd

Muller & Phipps (India) Ltd

₹ 570 -1.99%
21 Nov - close price
About

Incorporated in 1917, Muller & Phipps (India) is engaged in marketing of over the counter medical preparation and home care products.

Key Points

Product Profile:[1]
a) Cavisan - Medicated Dental Cream[2]
b) Cavifast - Medicated Dental Cream[3]
c) Cavisan - Gum Astringent[4]
d) Nixoderm[5]

  • Market Cap 35.6 Cr.
  • Current Price 570
  • High / Low 726 / 173
  • Stock P/E
  • Book Value -23.8
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value 10.0

Pros

  • Company has reduced debt.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 2.05% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Retail Industry: Trading

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
1.05 1.00 0.86 1.09 0.95 0.92 0.95 1.39 1.19 0.76 0.79 1.49 1.21
0.88 0.94 0.87 1.03 0.98 0.93 0.90 1.13 1.05 0.87 1.10 1.48 1.49
Operating Profit 0.17 0.06 -0.01 0.06 -0.03 -0.01 0.05 0.26 0.14 -0.11 -0.31 0.01 -0.28
OPM % 16.19% 6.00% -1.16% 5.50% -3.16% -1.09% 5.26% 18.71% 11.76% -14.47% -39.24% 0.67% -23.14%
0.06 0.16 0.09 0.06 0.06 0.06 0.07 0.06 0.06 0.08 0.62 0.06 0.06
Interest 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01
Depreciation 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax 0.20 0.19 0.05 0.10 0.01 0.03 0.10 0.30 0.18 -0.05 0.30 0.06 -0.23
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.20 0.19 0.06 0.10 0.01 0.03 0.09 0.29 0.18 -0.05 0.30 0.06 -0.23
EPS in Rs 3.20 3.04 0.96 1.60 0.16 0.48 1.44 4.64 2.88 -0.80 4.80 0.96 -3.68
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
4.26 3.67 4.50 3.47 3.40 3.13 3.74 3.61 3.97 3.67 3.91 4.14 4.25
4.89 3.75 4.88 3.60 3.40 3.10 3.37 3.51 3.72 3.50 3.87 4.18 4.94
Operating Profit -0.63 -0.08 -0.38 -0.13 0.00 0.03 0.37 0.10 0.25 0.17 0.04 -0.04 -0.69
OPM % -14.79% -2.18% -8.44% -3.75% 0.00% 0.96% 9.89% 2.77% 6.30% 4.63% 1.02% -0.97% -16.24%
0.13 0.18 1.14 0.38 0.30 0.19 0.09 0.40 1.61 0.38 0.26 0.83 0.82
Interest 0.54 0.31 0.31 0.31 0.24 0.24 0.21 0.14 0.12 0.10 0.08 0.06 0.05
Depreciation 0.03 0.03 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00
Profit before tax -1.07 -0.24 0.44 -0.07 0.05 -0.03 0.24 0.35 1.73 0.44 0.21 0.72 0.08
Tax % 0.00% 0.00% 0.00% 0.00% 20.00% 0.00% 20.83% 0.00% 0.00% 0.00% 0.00% 0.00%
-1.08 -0.23 0.44 -0.07 0.04 -0.03 0.19 0.35 1.73 0.43 0.21 0.73 0.08
EPS in Rs -17.28 -3.68 7.04 -1.12 0.64 -0.48 3.04 5.60 27.68 6.88 3.36 11.68 1.28
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 1%
5 Years: 2%
3 Years: 1%
TTM: -4%
Compounded Profit Growth
10 Years: 13%
5 Years: 12%
3 Years: -5%
TTM: -154%
Stock Price CAGR
10 Years: 21%
5 Years: 91%
3 Years: 55%
1 Year: 166%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.63 0.63 0.63 0.63 0.63 0.63 0.63 0.63 0.63 0.63 0.63 0.63 0.63
Reserves -5.72 -5.96 -5.52 -5.59 -5.52 -5.55 -5.35 -4.98 -3.29 -2.86 -2.65 -1.92 -2.12
1.73 1.87 1.86 1.85 1.85 1.85 2.00 1.86 1.59 1.31 1.04 0.77 0.73
7.93 7.87 7.70 7.60 7.63 7.54 7.53 7.37 5.74 5.76 5.95 5.78 6.21
Total Liabilities 4.57 4.41 4.67 4.49 4.59 4.47 4.81 4.88 4.67 4.84 4.97 5.26 5.45
0.12 0.09 0.08 0.07 0.04 0.05 0.04 0.07 0.07 0.06 0.05 0.06 0.06
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
4.45 4.32 4.59 4.42 4.55 4.42 4.77 4.81 4.60 4.78 4.92 5.20 5.39
Total Assets 4.57 4.41 4.67 4.49 4.59 4.47 4.81 4.88 4.67 4.84 4.97 5.26 5.45

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0.32 -0.07 0.53 0.03 0.07 0.16 -0.01 0.15 2.16 0.11 0.21 0.72
0.00 0.00 0.00 0.00 0.01 -0.02 0.00 -0.03 -0.01 0.00 0.00 -0.02
-0.32 0.09 -0.50 -0.04 -0.03 -0.07 0.10 -0.26 -1.76 -0.38 -0.34 -0.32
Net Cash Flow 0.00 0.02 0.03 -0.01 0.04 0.07 0.09 -0.14 0.39 -0.27 -0.13 0.39

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 33.42 31.83 51.10 50.49 59.04 40.81 40.01 30.33 45.05 71.61 88.68 73.18
Inventory Days 13.04 4.03 3.13 2.04 8.44 13.42 16.17 34.30 26.55 45.03 36.08 32.09
Days Payable 498.62 580.77 466.82 530.17 535.90 652.17 552.12 580.57 455.70 504.84 481.72 429.18
Cash Conversion Cycle -452.16 -544.91 -412.59 -477.64 -468.41 -597.94 -495.94 -515.94 -384.10 -388.20 -356.96 -323.91
Working Capital Days -357.29 -437.60 -313.09 -429.16 -425.12 -478.12 -391.35 -387.24 -186.64 -173.05 -152.16 -140.18
ROCE %

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
51.63% 51.63% 51.63% 51.63% 51.63% 51.63% 51.63% 51.63% 51.63% 51.63% 51.63% 51.63%
0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%
48.36% 48.36% 48.36% 48.37% 48.36% 48.35% 48.36% 48.36% 48.36% 48.36% 48.36% 48.36%
No. of Shareholders 1,8581,8411,8031,7941,7761,7631,7651,7571,7601,7701,7691,791

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents